Teva Sued by Hedge Funds for Late Disclosure of DOJ Subpoena

Hedge fund investors are suing generics manufacturer Teva for not being forthcoming about a federal price-fixing investigation — saying the company’s false statements before the eventual reveal of a subpoena resulted in losses of billions in shareholder value.
Source: Generic Line